NovaOnco Therapeutics Co., Ltd.
3 clinical trials · Sponsor
◉ Watch NovaOnco Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation (NCT06936527) | NovaOnco Therapeutics Co., Ltd. | 2025-05-23 |
| A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies (NCT06820268) | NovaOnco Therapeutics Co., Ltd. | 2025-01-14 |
| A Study of XS-02 Capsules in Patients With Advanced Solid Tumors (NCT06531486) | NovaOnco Therapeutics Co., Ltd. | 2024-07-29 |
Track NovaOnco Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.